EMEA-001016-PIP01-10-M01
Key facts
| Active substance |
Chemically modified extract of grass pollen from Holcus lanatus, Phleum pratense and Poa pratensis
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/0084/2019
|
| PIP number |
EMEA-001016-PIP01-10-M01
|
| Pharmaceutical form(s) |
Coated tablet
|
| Condition(s) / indication(s) |
Treatment of allergic rhinitis / rhino-conjunctivitis
|
| Route(s) of administration |
Sublingual use
|
| Contact for public enquiries |
Lofarma S.p.A.
|
| Decision type |
RPM: decision refers to a refusal on the application for modification of an agreed PIP
|